Bartlett & Co Wealth Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $116K | Sell |
1,402
-35
| -2% | -$3.21K | ﹤0.01% | 544 |
|
|
2025
Q4 | $130K | Hold |
1,437
| – | – | ﹤0.01% | 512 |
|
|
2025
Q3 | $142K | Buy |
1,437
+35
| +2% | +$3.47K | ﹤0.01% | 496 |
|
|
2025
Q2 | $128K | Sell |
1,402
-51
| -4% | -$4.93K | ﹤0.01% | 499 |
|
|
2025
Q1 | $165K | Sell |
1,453
-109
| -7% | -$11.7K | ﹤0.01% | 469 |
|
|
2024
Q4 | $165K | Sell |
1,562
-1,490
| -49% | -$160K | ﹤0.01% | 472 |
|
|
2024
Q3 | $330K | Hold |
3,052
| – | – | ﹤0.01% | 388 |
|
|
2024
Q2 | $332K | Hold |
3,052
| – | – | 0.01% | 378 |
|
|
2024
Q1 | $404K | Sell |
3,052
-240
| -7% | -$30K | 0.01% | 352 |
|
|
2023
Q4 | $401K | Sell |
3,292
-200
| -6% | -$22.3K | 0.01% | 375 |
|
|
2023
Q3 | $393K | Hold |
3,492
| – | – | 0.01% | 365 |
|
|
2023
Q2 | $509K | Buy |
3,492
+1,800
| +106% | +$245K | 0.01% | 343 |
|
|
2023
Q1 | $219K | Hold |
1,692
| – | – | ﹤0.01% | 368 |
|
|
2022
Q4 | $216K | Hold |
1,692
| – | – | ﹤0.01% | 376 |
|
|
2022
Q3 | $177K | Sell |
1,692
-39
| -2% | -$4.28K | ﹤0.01% | 387 |
|
|
2022
Q2 | $182K | Sell |
1,731
-887
| -34% | -$105K | ﹤0.01% | 387 |
|
|
2022
Q1 | $335K | Sell |
2,618
-79
| -3% | -$9.52K | 0.01% | 336 |
|
|
2021
Q4 | $333K | Hold |
2,697
| – | – | 0.01% | 340 |
|
|
2021
Q3 | $384K | Sell |
2,697
-91
| -3% | -$13.4K | 0.01% | 279 |
|
|
2021
Q2 | $436K | Sell |
2,788
-28
| -1% | -$4.54K | 0.01% | 272 |
|
|
2021
Q1 | $438K | Buy |
2,816
+51
| +2% | +$7.9K | 0.01% | 273 |
|
|
2020
Q4 | $414K | Hold |
2,765
| – | – | 0.01% | 272 |
|
|
2020
Q3 | $366K | Sell |
2,765
-27
| -1% | -$3.53K | 0.01% | 264 |
|
|
2020
Q2 | $324K | Sell |
2,792
-1,356
| -33% | -$156K | 0.01% | 271 |
|
|
2020
Q1 | $408K | Hold |
4,148
| – | – | 0.01% | 245 |
|
|
2019
Q4 | $604K | Sell |
4,148
-760
| -15% | -$105K | 0.01% | 247 |
|
|
2019
Q3 | $655K | Buy |
4,908
+752
| +18% | +$97.1K | 0.02% | 231 |
|
|
2019
Q2 | $476K | Sell |
4,156
-94
| -2% | -$11K | 0.02% | 210 |
|
|
2019
Q1 | $528K | Buy |
4,250
+8
| +0.2% | +$909 | 0.02% | 197 |
|
|
2018
Q4 | $428K | Sell |
4,242
-937
| -18% | -$105K | 0.02% | 207 |
|
|
2018
Q3 | $662K | Buy |
5,179
+108
| +2% | +$12.8K | 0.02% | 186 |
|
|
2018
Q2 | $550K | Buy |
5,071
+3
| +0.1% | +$327 | 0.02% | 196 |
|
|
2018
Q1 | $538K | Buy |
+5,068
| New | +$589K | 0.02% | 192 |
|
Other funds holding ZBH
VCM
VPM
Bartlett & Co Wealth Management's ZBH Position: Q1 2026 in Review
Bartlett & Co Wealth Management reduced its Zimmer Biomet (ZBH) stake by 2.4% in Q1 2026, selling an estimated $3.21K and leaving 1,402 shares worth $116K. The position accounts for ﹤0.01% of the portfolio, ranked #544.
Bartlett & Co Wealth Management first reported a position in ZBH in Q1 2018 and has held it in 33 quarters since. The position peaked at $662K in Q3 2018. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Bartlett & Co Wealth Management held 1,402 shares of Zimmer Biomet worth $116K as of Q1 2026.
- Bartlett & Co Wealth Management sold 35 Zimmer Biomet shares in Q1 2026, an estimated $3.21K.
- Zimmer Biomet made up ﹤0.01% of Bartlett & Co Wealth Management's portfolio in Q1 2026, its #544 holding.
- Bartlett & Co Wealth Management first reported a position in Zimmer Biomet in Q1 2018 and has held it in 33 quarters since.
- Bartlett & Co Wealth Management's Zimmer Biomet position peaked at $662K in Q3 2018.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Bartlett & Co Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.